The ENDEAVOR - Small Vessell Stenting (SVS) Registry
Description of Research
The primary objective of this study is to assess the safety and efficacy of the Endeavor stent in the treatment of single de novo lesions in small native coronary arteries.
The patient is > 18 years of age. The patient has clinical evidence of ischemic heart disease, stable or unstable angina, silent ischemia, or a positive functional study. The patient is an acceptable candidate for PTCA, stenting, and emergent CABG surgery. Additional screening criteria.